MEDTECH & DIAGNOSTICS CEPTON strategies, a Management Consulting firm for Healthcare Industries
A VERY INNOVATIVE AND SHORT-CYCLED SECTOR IN A COMPLEX ECONOMIC ENVIRONMENT.
MedTech and diagnostic segments typically have much short cycles than pharmaceuticals. Time to market and innovation are two critical success factors, however market access processes are complicated and often slow, especially when entering new and foreign markets.
CEPTON helps its clients navigate this difficult environment by designing creative business models and commercial strategies. Our approach uses all factors that influence commercial success, such as competitive positioning and market access strategy. Our expertise enables us to effectively review your resources and demonstrate how to best utilise your value chain to get the best out of your product.
Discover our other fields of intervention:
Molecular in-vitro diagnostic and medical imaging.
Our partners’ expertise allows us to quickly assess the potential and opportunities of a technological innovation in the field of diagnostics.
The industry of in-vitro and in-vivo diagnostics has gone through an extremely active phase of innovation in the last decade.
CEPTON has provided valuable support to numerous companies to best utilize their value proposition and maximize the commercial potential of their innovation.
The integration of new technologies in the everyday work of medical practitioners needs new commercial approaches.
The profusion of innovations in the field of surgery brought by new information technologies and miniaturization creates new opportunities for healthcare industries but also new challenges when it comes to commercial models. The service associated with each product becomes more and more important, and has potentially huge implications on our clients' commercial organizations.
Next Generation Sequencing (NGS).
We continuously monitor developments in NGS. The abundance of data that NGS will generate may facilitate a greater understanding in the role played by genetics in numerous pathologies. We help our clients adapt to emerging technologies and implement relevant changes into their R&D strategies.
We also help clients develop patient stratification strategies to generate the optimum benefits and cost ratio. We demonstrate what effect it will have on their pricing and market access strategies.
«Rapidly gain access to markets and maintain a continuous flow of innovations.»